Ageing and Parkinson's disease: why is advancing age the biggest risk factor? - Test2 - elhamkhani - TriplyDB

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

http://www.wikidata.org/entity/Q27021628

about

Orphan proteins of unknown function in the mitochondrial intermembrane space proteome: New pathways and metabolic cross-talk mHealth For Aging China: Opportunities and Challenges Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods Integration of 'omics' data in aging research: from biomarkers to systems biology Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells Genome-wide analysis of DNA methylation during antagonism of DMOG to MnCl2-induced cytotoxicity in the mouse substantia nigra.Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson's Disease Systems biology of neurodegenerative diseases Parkinson's disease as a result of aging Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report)On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's Disease Age-Related Decline in the Variation of Dynamic Functional Connectivity: A Resting State Analysis The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats.Eryptosis as a marker of Parkinson's disease Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model.Neuroprotective effects of porphyran derivatives against 6-hydroxydopamine-induced cytotoxicity is independent on mitochondria restoration.Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.Age-related neurodegenerative disease research needs aging models Drosophila Clock Is Required in Brain Pacemaker Neurons to Prevent Premature Locomotor Aging Independently of Its Circadian Function.Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease.The epigenetic role of vitamin C in health and disease.Differences in vulnerability of neurons and astrocytes to heme oxygenase-1 modulation: Implications for mitochondrial ferritin Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes.Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson's Disease The Effects of Crocin on 6-OHDA-Induced Oxidative/Nitrosative Damage and Motor Behaviour in Hemiparkinsonian Rats.Segmental Aging Underlies the Development of a Parkinson Phenotype in the AS/AGU Rat.Back to the tubule: microtubule dynamics in Parkinson's disease.Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.Effect of aging on stem cells.HDL and cholesterol handling in the brain.The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential.Aging and computational systems biology.

P2860

Q26739994-D3C669EB-5604-4639-A527-53741D35E71B Q26773996-4BEEA7E8-C304-4D7E-B61A-A940493BF1BC Q26778937-17EC84DA-42D1-4EB0-9E25-109A2B682FE5 Q26779470-C40169CA-5C3B-46CD-BD59-DF3F068CA137 Q26786552-084842E9-7AE9-4DB7-8B3D-D50928632420 Q27329722-B839E9EF-EA58-4DF4-AAF4-144BC2FC8A03 Q27334222-3C485ABD-9BFA-4CC5-B340-EDF699B450F1 Q28074143-276E3AA5-6ACC-4A6A-8506-FCAB89A7E42A Q28076243-3F72C59A-D7C3-4398-BC43-AB9B18B34B79 Q28079187-42ADC18F-5CAA-47BC-8FA7-6ECCE78CCB6E Q28080741-68B0297A-3B37-481E-B51A-2A2F6A672F94 Q28084395-EFC7AFA1-36EA-46AE-9E7F-0917BA6896A3 Q28386662-33039754-8A94-4DF7-BBA0-55F45FF9A260 Q28830683-9FADEA99-04BD-480B-A656-93D39274A708 Q33714263-0F91C953-186C-4A56-A89E-6DE5ABD1151F Q33844949-A66937B9-A538-47D4-AE97-56650CFC88D7 Q33854480-C5A588C1-4D04-4295-A418-2FE573A86A7F Q33872721-599395F8-D40B-47BE-97C7-DAE09B67F526 Q34585744-8D79FF79-E2DA-4CE3-BA58-DB2D0D8DE574 Q34625750-E6F75C02-9F64-433E-9378-E67796877AEB Q35169174-2F6DB76D-2757-483D-97B7-5BA53662BC93 Q35834043-3A9AC664-6156-4558-8821-E5A5290785CD Q36018230-57B13C0A-8392-4762-9DBD-71A1D79DB3F0 Q36245410-E2721388-27C6-4C4D-A323-B8B3C9078BBE Q36373170-3DE6E87C-4819-4897-A5C6-CA9CB8B6FAD6 Q36611143-AC4C7BCC-5116-47A1-993A-6006F5B635E7 Q36723214-C3F51563-0938-4622-B45C-506FC9D15182 Q36819703-616CF20E-7FB4-4688-990D-C516A2D0FF4C Q36969070-4FA02449-8C4E-43F3-B168-AEB2B393E558 Q37024972-95D88171-2684-450F-AA42-00FB81E1334A Q37530698-CD3FE60D-8E5E-406D-A39E-031FC1D0D5BD Q37533588-601E1B60-35B4-4CF5-8D36-DD72F0CC3188 Q37590635-A24A3282-80FB-42F1-93DF-38F6795ED686 Q37591146-50F93F21-2A33-4EEF-8C23-26184623D454 Q37652063-E2EF4AFF-AA94-46F2-AFF7-15C38A9325F2 Q38218439-5F76CFDB-9B8D-45A9-9434-178AD9B7DD84 Q38242194-D33E2103-C4AF-462E-98E4-8CF5BAF46769 Q38563981-4032845F-327C-411A-83E2-7FF39A2F7356 Q38683914-D4CE8E9D-9DFC-44C6-974C-385441384020 Q38716151-88C776CE-84FE-4732-8018-4F5EF986AA18

P2860

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

http://www.wikidata.org/entity/Q27021628

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@ast

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@en

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@nl

type

label

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@ast

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@en

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@nl

prefLabel

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@ast

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@en

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@nl

P1433

Q27021628-B3F15C48-246A-4158-8BF7-C5F0A9EC199A

P1476

Q27021628-C44FB08D-68CE-4E62-8D99-134133BC5209

P2093

Q27021628-087198BC-7174-4F07-B51C-3C09DBBCF1BE

Q27021628-39105F0C-1D4C-447B-84B9-8274BAE784EA

P275

Q27021628-038EF93E-53A0-42DF-BFD4-26533F61BBDE

P2860

Q27021628-0111B9F4-1AA1-4EB4-A184-911807F99500

Q27021628-07888339-93F6-42D4-873A-7C5DBDA4D896

Q27021628-0EF56E05-5146-47BA-8331-55DE0ABE2BBE

Q27021628-1380819F-653C-433D-B327-E996A3C788C4

Q27021628-1551748E-9575-470F-8CBB-9C34DA7BCA90

Q27021628-1B8A763E-09C5-4EB4-9D0A-80EF8002F460

Q27021628-1D66CA43-F52A-4CA8-B52C-96FC21FBDAF6

Q27021628-2324B7E9-5098-463B-9FAD-7A959EB9C3EF

Q27021628-238A41D1-8A8F-49AF-8C9A-9A23BBE1400F

Q27021628-23E035BE-F8D0-44B9-8554-0A920ACBAFFB

P304

Q27021628-4F2CE910-3D91-4137-9BA0-1D8A720CCC14

P31

Q27021628-5C3408B7-12EB-4C06-A298-1D22F47A5F57

P3181

Q27021628-0B8D2BE1-47B6-4A33-AD2A-4FDA0C8FEEE6

P356

Q27021628-B3613D59-C6DF-4DC2-8565-CE83DBD12965

P407

Q27021628-81275150-6B5A-4C7F-BB95-8332B9EEC1E7

P478

Q27021628-609EC421-1776-49EC-B8A0-B3407E59DB0D

P50

Q27021628-3BC846AB-8614-4375-9222-2CAA2AE997ED

P5008

Q27021628-888D0240-F8DE-4552-B53A-FD8BB926B627

P577

Q27021628-F724C96B-12C4-4CDC-B9BB-BD29292CAF8C

P5875

Q27021628-1BAB07CD-30C9-4D48-86D8-F11C176D0A93

P698

Q27021628-60FF0EBB-6061-4520-B192-AC55AA8D3722

P921

Q27021628-2D9BE609-AEA7-43CD-9FD2-36AAD8559E73

Q27021628-33562A28-07D5-4478-AD66-2272117D7300

Q27021628-5575218B-E57F-483B-BEF2-FD5F1C37D1FB

Q27021628-60F018BA-49CF-48C7-8C55-983981F8DB43

Q27021628-AEE1783A-B84D-4974-B154-641558E2200F

P932

Q27021628-32362EC2-793C-44E7-A1AB-0C18031FBBB0

P3181

P356

J.ARR.2014.01.004

P1433

Ageing Research Reviews

P1476

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

@en

P2093

Amy Reeve

http://www.w3.org/2001/XMLSchema#string

Eve Simcox

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Premature ageing in mice expressing defective mitochondrial DNA polymerase

Fission and selective fusion govern mitochondrial segregation and elimination by autophagy

Chaperone-mediated autophagy markers in Parkinson disease brains

Protein misfolding, functional amyloid, and human disease

Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

Loss of autophagy in the central nervous system causes neurodegeneration in mice

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports

Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour

P304

19-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

226882

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.ARR.2014.01.004

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Doug M Turnbull

P5008

P577

2014-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260119399

http://www.w3.org/2001/XMLSchema#string

P698

24503004

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

physiological phenomena

P932

3989046

http://www.w3.org/2001/XMLSchema#string